Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Andy I. Chen
Oregon Health and Science University
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
73
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Efficacy of Polatuzumab Vedotin + Obinutuzumab for Relapsed/Refractory NHL: A Phase 1b/2 Study
Number of pages: 29
Posted: 08 Mar 2021
Tycel Phillips
,
Mark Brunvand
, Andy I. Chen,
James Essell
,
Annalisa Chiappella
,
Catherine Diefenbach
,
Ji Cheng
,
David Ramies
,
Jamie Hirata
,
Franck Morschhauser
and
Ian W. Flinn
University of Michigan at Ann Arbor - University of Michigan Medical School, Oregon Health and Science University, Oregon Health and Science University, Oncology Hematology Care Inc., Città Della Salute e della Scienza, New York University (NYU) - Laura and Isaac Perlmutter Cancer Center, Roche, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, University Hospital of Lille and Sarah Cannon Research Institute/Tennessee Oncology, PLLC
Downloads
73
(852,604)
View PDF
Download
Abstract:
Feedback